Relafen 750, the unique compound of naproxen, offers a fascinating study from our biochemical pharmacy perspective. The mode of action, primarily involving inhibition of cyclooxygenase enzymes – COX-1 and COX-2 – results to a reduction in prostaglandin creation. From our biochemical lens, it drug's efficacy is closely related to its ability to